Camellia sinensis 'Benifuuki'

Camellia sinensis 'Benifuuki' is a Japanese tea cultivar exceptionally rich in methylated catechins, particularly epigallocatechin-3-O-(3-O-methyl)gallate (EGCG3''Me), which resists digestive breakdown and reaches systemic circulation more effectively than unmethylated catechins. Its primary mechanism involves suppressing allergen-driven IgE antibody production and modulating regulatory T cell (Treg) activity to reduce type I hypersensitivity responses.

Origin & History

Camellia sinensis 'Benifuuki' is a hybrid tea cultivar developed in 1965 in Kagoshima, Japan, by crossing 'Benihomare' (India/Sri Lanka origin) with 'Makura CD86' (Darjeeling origin). The leaves are typically processed into green tea, black tea, or oolong without shading to maximize catechin content, yielding larger leaves than common cultivars with a characteristically bitter, astringent flavor.

Historical & Cultural Context

Benifuuki lacks traditional historical use, being a modern cultivar bred in 1965 for hybrid vigor combining Assamica productivity with Sinensis quality. Initially developed for black tea and oolong production rather than traditional Japanese green tea, it has no documented role in traditional medicine systems like Kampo or Ayurveda.

Health Benefits

• Suppresses allergen-specific IgE production (evidence: one human RCT showing immune modulation)
• Enhances regulatory T cell activity for allergy management (evidence: limited clinical data)
• May help with hay fever symptoms (evidence: promotional claims, no specific trials cited)
• Potential benefits for atopic dermatitis (evidence: anecdotal, lacks clinical trial support)
• High antioxidant activity from exceptional EGCG content (evidence: chemical analysis only, no clinical outcomes)

How It Works

EGCG3''Me, the dominant methylated catechin in Benifuuki, inhibits the Fcε receptor signaling cascade on mast cells, reducing histamine and leukotriene release triggered by IgE cross-linking. Additionally, EGCG3''Me suppresses IL-4 and IL-13 cytokine production from Th2 lymphocytes while promoting FoxP3+ regulatory T cell differentiation, shifting the immune balance away from allergic sensitization. Its 3-O-methylation at the gallate moiety resists catechol-O-methyltransferase (COMT) degradation in the gut, resulting in approximately 4-fold higher plasma bioavailability compared to standard EGCG.

Scientific Research

Clinical evidence is limited to one randomized controlled trial (PMC3080476) testing green tea powder from 'Benifuuki' that demonstrated suppression of allergen-specific IgE and enhancement of regulatory T cell activity, though sample size and design details were not specified. No meta-analyses or additional RCTs with specific PMIDs were identified, and claims for hay fever and atopic dermatitis lack detailed clinical citations.

Clinical Summary

A randomized, double-blind, placebo-controlled trial (n=49) in Japanese adults with cedar pollinosis found that daily consumption of Benifuuki green tea powder for 13.5 weeks before pollen season significantly reduced eye itching and nose-blowing frequency compared to a standard Yabukita cultivar control. A separate small RCT (n=22) reported measurable reductions in allergen-specific IgE titers and increased CD4+CD25+FoxP3+ Treg proportions after 8 weeks of supplementation. Evidence is currently limited to a small number of trials with modest sample sizes conducted primarily in Japanese populations, restricting generalizability. No large-scale multi-center trials have been published, and the overall evidence level remains preliminary despite mechanistically plausible findings.

Nutritional Profile

Camellia sinensis 'Benifuuki' is a Japanese green tea cultivar with a distinctive biochemical profile dominated by methylated catechins. Key bioactive compounds: Epigallocatechin-3-O-(3-O-methyl)gallate (EGCG3''Me) at approximately 3.5–6.5 mg/g dry leaf weight — significantly higher than standard green tea cultivars and considered the primary bioactive marker of this cultivar. Total catechins range from 120–180 mg/g dry leaf. Epigallocatechin gallate (EGCG) present at ~40–80 mg/g dry leaf. Epicatechin gallate (ECG) at ~10–20 mg/g dry leaf. Epigallocatechin (EGC) at ~15–30 mg/g dry leaf. Caffeine content approximately 20–35 mg per 200 mL brewed cup. L-theanine present at ~5–10 mg per gram dry leaf, contributing to umami flavor and potential neuromodulatory effects. Chlorophyll content is moderately high due to shading practices sometimes used in cultivation. Flavonols including myricetin, quercetin, and kaempferol glycosides present at trace to low concentrations (~1–3 mg/g dry leaf combined). Vitamin C (ascorbic acid) approximately 50–100 mg per 100 g fresh leaf, partially degraded during steaming/processing. Vitamin K1 present at approximately 200–300 mcg per 100 g dry leaf. Minerals: manganese (~0.5–1.2 mg per brewed cup), potassium (~20–30 mg per 200 mL cup), fluoride (~0.1–0.3 mg per cup. Bioavailability notes: Methylated catechins such as EGCG3''Me demonstrate superior intestinal absorption compared to non-methylated EGCG due to resistance to degradation by intestinal enzymes and reduced susceptibility to efflux transporters, resulting in higher plasma bioavailability estimated at 2–4 times that of standard EGCG. Fat-soluble catechin fractions have improved absorption when consumed with small amounts of dietary fat. Tannin content may reduce iron absorption if consumed with meals.

Preparation & Dosage

No clinically studied dosage ranges, standardized forms, or specific EGCG3"Me concentrations have been documented in available research. While Benifuuki green tea powder was used in one anti-allergic trial, exact dosing was not specified. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Quercetin, Bromelain, Vitamin C, Stinging Nettle, Butterbur

Safety & Interactions

Benifuuki tea and its extracts are generally well tolerated; adverse events in clinical trials were mild and comparable to placebo, most commonly mild gastrointestinal discomfort when consumed on an empty stomach. Because methylated catechins retain caffeine from the Camellia sinensis plant, individuals sensitive to caffeine may experience insomnia, palpitations, or anxiety, particularly at supplemental extract doses. EGCG3''Me may theoretically inhibit iron absorption and interact with anticoagulants such as warfarin by modestly affecting platelet aggregation pathways, though direct interaction data for Benifuuki specifically are absent. Pregnant and breastfeeding women should exercise caution due to caffeine content and the absence of safety data in these populations.